SUBSTANCE: invention provides a method for producing a heterogenous skin cell population implying the sampling of a skin biopsy material at a depth of 2 mm, tissue homogenisation in 0.9% aqueous sodium chloride at temperature +23 … +25°C, recovery of homogenate, filtration of the homogenate through an inert filter cloth with the pore diameter of 20 mcm, centrifugation of the homogenate at 400 g for 5 minutes at temperature +23 … +25 C.
EFFECT: skin cell separation and viability preservation.
The release of Matrix GO version Y with all the bells and whistles and compliance with all the requirements is already being actively implemented in clinics.number of pragmatic solutions for managing the clinic are offered. Do not wait for new requirements to take you by surprise!e!
On January 4, 2026, it will be exactly three years since I returned to the pool after a thirty-year hiatus...
The assessment of the safety of products supplied to the market, without which the sale is impossible and illegal, protecting the consumer's health, does not guarantee him the effectiveness declared by the manufacturer. Meanwhile, there has long been equipment for assessing skin parameters, which in the hands of specialists can be used to objectively assess the effectiveness of cosmetic products and hardware methods.
In more detail...
